Atelerix raises seed funding from UK Innovation & Science Seed Fund, Newable Private Investing, and Oxford Technology Management.
The funding round was led by UK Innovation & Science Seed Fund to support the commercialisation of the company products.
Atelerix develops a gel-based system designed for storing and transporting cells and tissues at room temperature without freezing.
Atelerix has closed a seed funding round of an undisclosed amount. The investment was led by UK Innovation & Science Seed Fund, alongside new backers Newable Private Investing and Oxford Technology Management.
The company will use the capital to bring its cell storage products to market. Atelerix commercialises hydrogel technology that allows viable cells, including stem cells and cell-based assays, to be stored and transported at ambient temperatures.
Following the transaction, Dr Andrew Muir of UK Innovation & Science Seed Fund has joined the board of directors.
Use of funds
- 01Continue product development
- 02Accelerate go-to-market
